Oxidation of acetaminophen to its toxic quinone imine and nontoxic catechol metabolites by baculovirus-expressed and purified human cytochromes P450 2E1 and 2A6

Chemical Research in Toxicology
W ChenS D Nelson

Abstract

Acetaminophen (APAP), a widely used analgesic and antipyretic agent, is bioactivated by cytochromes P450 to cause severe hepatotoxicity. APAP is oxidized by two pathways to form a toxic intermediate, N-acetyl-p-benzoquinone imine (NAPQI), and a nontoxic catechol metabolite, 3-hydroxy-APAP (3-OH-APAP). We investigated the role of P450 2E1 and 2A6 in APAP oxidation by using baculovirus-expressed and highly purified forms of human P450 2E1 and 2A6. An electrochemical HPLC assay was developed to quantify both oxidative metabolites simultaneously. For the first time, it was demonstrated that human P450 2E1 selectively oxidized APAP to NAPQI (assayed as its glutathione conjugate, GS-APAP), whereas human P450 2A6 selectively oxidized APAP to 3-OH-APAP. At 1 mM APAP, the relative ratio for the formation of GS-APAP vs 3-OH-APAP with human P450 2E1 was approximately 6:1, whereas the ratio with human P450 2A6 was 1:3. Apparent Km and Vmax values for the formation of GS-APAP by human P450 2E1 were 1.3 mM and 6.9 nmol/min/nmol of P450, respectively, whereas they were 4.6 mM and 7.9 nmol/min/nmol of P450 for P450 2A6. Apparent Km and Vmax values for the formation of 3-OH-APAP by human P450 2E1 were 4.0 mM and 2.5 nmol/min/nmol of P450, respe...Continue Reading

References

Jan 1, 1992·Critical Reviews in Toxicology·S A Wrighton, J C Stevens
Jan 1, 1989·Drug Metabolism Reviews·H W StrobelD R Nelson
Jan 1, 1988·Chemical Research in Toxicology·P J HarvisonS D Nelson
Aug 1, 1993·Clinical Pharmacology and Therapeutics·R ZandJ M Wright
Sep 1, 1996·Clinical Pharmacology and Therapeutics·J T SlatteryK E Thummel
Oct 1, 1996·Chemical Research in Toxicology·M BourdiL R Pohl

❮ Previous
Next ❯

Citations

Oct 2, 2001·Medicinal Research Reviews·G N Kumar, S Surapaneni
Aug 2, 2003·Archives of Biochemistry and Biophysics·Edelmira ValeroFrancisco García-Carmona
Jan 23, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D F V LewisP S Goldfarb
Mar 26, 2003·Toxicology in Vitro : an International Journal Published in Association with BIBRA·D F V LewisP S Goldfarb
Apr 12, 2000·British Journal of Clinical Pharmacology·L F Prescott
Dec 21, 2000·Journal of Clinical Pharmacy and Therapeutics·E TanakaS Misawa
Jul 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Ping ZhaoJohn T Slattery
Dec 21, 2006·Toxicologic Pathology·Alan M JeffreyGary M Williams
Apr 20, 2004·Assay and Drug Development Technologies·Bryan D MarksOlga V Trubetskoy
May 23, 2009·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jie ChengFrank J Gonzalez
Jan 30, 2003·Biological Chemistry·Edelmira ValeroFrancisco García-Carmona
Dec 22, 2012·Drug Metabolism and Pharmacokinetics·Yune-Fang UengPei-Lun Tsai
Mar 5, 2013·Trends in Pharmacological Sciences·Derick HanNeil Kaplowitz
Jan 5, 2002·Proceedings of the National Academy of Sciences of the United States of America·Peter D SenterRichard Bucala
Nov 12, 2005·Journal of Biological Inorganic Chemistry : JBIC : a Publication of the Society of Biological Inorganic Chemistry·Michael FairheadGianfranco Gilardi
Jan 6, 2006·Drug Metabolism Reviews·P David Josephy
Nov 28, 2006·Expert Opinion on Drug Metabolism & Toxicology·John Cl Erve
Nov 27, 2010·Drug Metabolism Reviews·Lizi Zhao, Gisèle Pickering
May 9, 2002·Drug Metabolism Reviews·Slobodan Rendic
Feb 17, 2009·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·J E LaineR O Juvonen
Jul 14, 2010·Pain Medicine : the Official Journal of the American Academy of Pain Medicine·Hazel PalmerRichard Day
Feb 7, 2016·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jeannine ChanJohn P Harrelson
Aug 1, 2015·Biochemical Pharmacology·Jessica H HartmanGrover P Miller
Jun 24, 2008·Disease-a-month : DM·Anne M Larson
Aug 29, 2007·Clinics in Liver Disease·Anne M Larson
Dec 13, 2006·Biochemical and Biophysical Research Communications·John P HarrelsonSidney D Nelson
Sep 9, 2015·Journal of Theoretical Biology·Dennis ReddyhoffSteven Webb
Jan 18, 2007·CNS Drug Reviews·Alfio BertoliniSheila Leone
Feb 6, 2010·Journal of Clinical Pharmacology·Ophelia Q P YinMoses S S Chow
Nov 28, 2012·International Journal of Clinical Practice. Supplement·J N van den Anker
Jan 3, 2013·Pediatrics International : Official Journal of the Japan Pediatric Society·Taku NakagawaMasafumi Matsuo
Nov 14, 2006·Life Sciences·Nagako TanakaHiroshi Yokota
Jul 10, 2004·Biochemical Pharmacology·Adam Holownia, Jan J Braszko
Jul 31, 2002·Biochemical Pharmacology·Robert H PierceSam A Bruschi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.